Clinilabs invites you to their event
About this event
This session will focus on common assessment tools used in neuropsychiatric clinical trials. These tools include self-report measures, clinician-rated instruments (e.g., MINI, SCID, HDRS, MADRS), and neuropsychiatric testing (cognitive assessment). We will cover paper-and-pencil assessments, digital assessments, and wearables.
Hosted by
Ms. Jeanine Falinski, VP of Strategy and Corporate Development, has more than 20 years of experience in the pharmaceutical industry. Jeanine graduated from Emerson College with a degree in New Media and Marketing, later on receiving her MBA in Pharmaceutical Management from Drexel University.
We are a global, full-service contract research organization (CRO), the only one focused exclusively on central nervous system (CNS) drug development. We are dedicated to bringing new therapies to patients living with mental health, neurological and substance abuse disorders.
